Effects of Transcutaneous Electrical Nerve Stimulation on Chemotherapy-Induced Peripheral Neuropathy

Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
University of Rochester NCORP Research Base
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT04367480
This phase II trial studies the effects of transcutaneous electrical nerve stimulation (TENS) for the treatment of peripheral neuropathy caused by chemotherapy, often called chemotherapy-induced peripheral neuropathy (CIPN). Peripheral neuropathy refers to the conditions that result when nerves that carry messages to and from the brain and spinal cord from and to the rest of the body are damaged or diseased. The TENS device emits high frequency electrical stimulation through the skin and may provide relief from chronic pain.
Placebo Administration, Questionnaire Administration, Transcutaneous Electrical Nerve Stimulation
Chemotherapy-Induced Peripheral Neuropathy
Jennifer Gewandter

See list of participating sites